Darunavir / cobicistat

Prazosin

Potential interaction.

No pharmaceutical opinion available for this interaction.

Mechanism

Darunavir / cobicistat can inhibit BCRP and increase the plasma concentration of Prazosin.

Darunavir / cobicistat

Pharmacodynamic effects

Recommendations

Alternative solution(s)

Prazosin

Pharmacodynamic effects

Clinical significance unknown.

Recommendations

Titrate dose based on patient response and tolerability.

Alternative solution(s)

Monitor

Tests

Pharmacokinetic parameters

Comment

Reference